BioSpace News Archive

The global market for smart e-pants has been expanding due to the need to improve health of disabled and bedridden persons.

Sodium hyaluronate is a high-molecular-mass, polysaccharide present in the extracellular matrix of connective tissues.

Lacrimal is an ophthalmic protective system that helps keep the eye moist and free of dust particles. Lacrimal devices are usually limited to the eye’s nasal punctum and lacrimal ducts.

Globally, people are becoming highly conscious about their appearance and giving importance to even minute details on their skin.

Biomarkers can be defined as objective measures that capture physiological, anatomic, and pathological characteristics of an individual to understand the state of the person and the warning signals being given by the body.

The demand within the global market for chemotherapy induced nausea and vomiting is expected to rise on account of the rising incidence of various types of cancers across the world.

Melzi Corporation has received the US Food and Drug Administration (FDA) registration and listing confirmation for the Melzi Sharps Finder and it is now listed for human use. The Melzi Sharps Finder is a device designed to help surgeons locate sharps in the surgical area during a lost sharps event. Lost sharps include needles, instruments, broken pieces, and fragments. This press release features multimedia. View the full

Olatec Therapeutics LLC announced today that patients are being enrolled in a trial described as: “A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome.”

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the third quarter ended September 30, 2020 after the close of the financial markets on Tuesday, November 3, 2020.

Company focused on development of novel drugs with clinically-validated mechanisms for the treatment of neurodevelopmental and neurodegenerative disorders Lead product candidate, EM-036, has demonstrated superior efficacy in preclinical Autism Spectrum Disorders